To include your compound in the COVID-19 Resource Center, submit it here.

DNA, XOMA delay Xanelim filing

Genentech (DNA) and partner Xoma (XOMA) said after market close on Thursday

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE